Technology
Health
Pharmaceutical

Aclaris Therapeutics

$0.8732
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0735 (9.19%) Today
$0.00 (0.00%) As of 4:50 PM EDT after-hours

Why Robinhood?

You can buy or sell ACRS and other stocks, options, ETFs, and crypto commission-free!

About ACRS

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Dermatology Therapeutics and Contract Research segments. Read More The Dermatology Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.

Employees
169
Headquarters
Malvern, Pennsylvania
Founded
2012
Market Cap
36.12M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.18M
High Today
$0.95
Low Today
$0.77
Open Price
$0.80
Volume
2.73M
52 Week High
$16.49
52 Week Low
$0.74

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
Biopharmaceutical
2015 IPO
US

ACRS News

ReutersAug 13

Edited Transcript of ACRS earnings conference call or presentation 8-Aug-19 9:00pm GMT

12

ACRS Earnings

-$1.33
-$1.14
-$0.95
-$0.76
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.76 per share
Actual
-$0.76 per share

More ACRS News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.